Chandan Healthcare Limited IPO

Chandan Healthcare Ltd

₹1,20,800 /800 sharesMinimum Investment

Chandan Healthcare Limited IPO Listing Details

Listed OnIssue PriceListing PriceListing Gains
--₹159.00₹165.10₹6.10 (3.84%)

Chandan Healthcare Limited IPO Details

Bidding DatesMin. InvestmentLot SizePrice Range
10 Feb ‘25 - 12 Feb ‘25₹1,20,800800₹151 - ₹159
Issue SizeIPO Doc
107.36Cr
RHP PDF

Subscription rate

As of 12 Feb'25, 05:00 PM
Qualified Institutional Buyers4.15x
Non-Institutional Investor17.13x
Retail Individual Investor1.77x
Employees0.16x
Total5.06x

About Chandan Healthcare Limited

Chandan Healthcare is a diagnostic services provider. The company offers pathology and radiology testing, along with medical consultation services. The company's test portfolio includes routine and specialised pathology tests, as well as imaging services like X-rays, ultrasounds, CT scans, and MRIs. Chandan Healthcare operates over 300 sample collection centres, seven central reference laboratories, and 26 satellite laboratories across tier-2 cities and towns in Uttar Pradesh, Uttarakhand, and Rajasthan. It follows a cluster and collection points model, where samples are gathered from designated locations and transported to central laboratories for testing.;
Founded in
2003
Managing director
Mr Amar Singh
Parent organisation
Chandan Healthcare Ltd

Strengths & Financials of Chandan Healthcare Limited

Strengths
Risks
Chandan Healthcare operates a diagnostic network across North India, with one flagship laboratory, seven central laboratories, 26 satellite centres, and over 300 sample collection centres. As of August 31, 2024, the company’s presence spans more than 15 cities and towns in Uttar Pradesh and over 10 in Uttarakhand.
The company claims to have a diverse test portfolio, offering 1,118 tests, including 169 routine pathology tests, 713 specialised pathology tests, and 236 radiology tests. Its radiology facilities reportedly include 11 CT scanners and four MRI machines.
Chandan Healthcare expands its reach in remote areas by following a cluster and collection points model, where samples from nearby areas are gathered and transported to central laboratories for testing.
The company has eight NABL-accredited laboratories and three of its diagnostic centres are NABH-accredited.
In FY24, Chandan Healthcare claims to have conducted approximately 61.77 lakh tests for 15.64 lakh patients.
The company has seen a consistent increase in revenue from operations. Revenue from operations increased from Rs 119.56 crore in FY22 to Rs 136.89 crore in FY23 to Rs 176.59 crore in FY24.
The company relies heavily on B2C customers and a few key clients for a major portion of its revenue. These customers contributed Rs 119.74 crore (67.80%) in FY24, Rs 92.79 crore (67.78%) in FY23, and Rs 98.95 crore (82.76%) in FY22 to the revenue from operations. Additionally, there are no long-term contracts with these customers, and the loss of any key accounts could negatively impact business operations and financial performance.
Pathology and radiology services form the core revenue stream, contributing 55.21% in FY24, 55.12% in FY23, and 51.43% in FY22. Any decline in the performance of these services could adversely impact the company’s overall business growth and profitability.
Chandan Healthcare’s operations are largely concentrated in Uttar Pradesh and Uttarakhand. The company derived Rs 119.62 crore (67.74%), Rs 94.47 crore (69.01%), and Rs 98.46 crore (82.35%) of its revenue from operations from Uttar Pradesh in FY24, FY23, and FY22, respectively, while revenue from Uttarakhand stood at Rs 56.97 crore (32.26%), Rs 42.42 crore (30.99%), and Rs 21.11 crore (17.65%) in the same periods. Any adverse political, social, or economic developments in these regions can negatively impact the company’s business, financial performance, and expansion plans.
The company is reliant on a few select customers for its revenue. The top 10 customers of the company contributed Rs 169.94 crore (96.23%) in FY24, Rs 126.47 crore (92.39%) in FY23, and Rs 113.09 crore (94.59%) in FY22 to the total revenue from operations. Any failure to retain these key customers, expand the customer base, or a loss of business from these clients can adversely affect the company’s business and financial standing.
The company is involved in ongoing legal proceedings. Any adverse judgments in any of these cases can be detrimental to the company’s business prospects.
The company had an outstanding financial indebtedness of Rs 35.48 crore as of August 31, 2024. Any failure to service or repay these loans can harm the company’s operations and financial position.
The company reported a loss of Rs 1.09 crore in FY22 and cannot assure that similar financial setbacks will not occur in the future. Any such losses could impact its financial stability and overall business operations.

Chandan Healthcare Limited Financials

*All values are in Rs. Cr
No Graph Data To Display

Application Details of Chandan Healthcare Limited IPO

Apply asPrice bandApply Range
Regular151 - 159₹2 - 5 Lakh
Employee136 - 144₹2 - 5 Lakh
High Networth Individual151 - 159₹2 - 5 Lakh
For Chandan Healthcare Limited IPO, eligible investors can apply as Regular & Employee.